Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 4, 2016, after the close
10-Q filed Aug 4, 2016, 35 days after period end · 0001299130-16-000235
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $20.75M | $24.94M | $11.43M | $6.05M |
| Net Income | -$18.50M | -$11.94M | -$19.14M | -$20.47M |
| EPS Diluted | -$0.21 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.16 |
| -$0.27 |
| -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
